Immunogenicity of a Single Dose of GSK Biologicals' Diphtheria, Tetanus and Acellular Pertussis (dTpa) Booster Vaccine (Boostrix™ ) in Infants Prior to Primary Pertussis Vaccination, When Administered to Pregnant Women as Per Routine Practice in Bogota, Colombia
Not yet recruiting
Phase of Trial: Phase IV
Latest Information Update: 30 Oct 2017
At a glance
- Drugs DTaP vaccine (Primary)
- Indications Diphtheria; Pertussis; Tetanus
- Focus Pharmacodynamics
- Sponsors GlaxoSmithKline
- 24 Oct 2017 Planned End Date changed from 8 Oct 2018 to 8 Nov 2018.
- 24 Oct 2017 Planned primary completion date changed from 8 Oct 2018 to 8 Nov 2018.
- 24 Oct 2017 Planned initiation date changed from 6 Nov 2017 to 19 Jan 2018.